// App-Quantinova.ai

P1638 : EARLY USE OF ELTROMBOPAG IN ADULT PATIENTS WITH ITP WHO ARE REFRACTORY OR RELAPSED AFTER FIRST-LINE CORTICOSTEROID THERAPY – AN AD HOC ANALYSIS OF THE TAPER TRIAL RESULTS

Researchers

Presenter

  • Waleed Ghanima

Principal Investigators

  • Francesco Zaja

  • Joan Maier

  • Jens Haenig

  • James Lee

  • Nichola Cooper

Medical Centers

  • Department of Medicine,Østfold Hospital Trust,Kalnes,Noruega

  • Novartis Pharmaceuticals Corporation East Hanover NJ United States

  • Department of Medical, Surgical and Health S

  • Department of Medicine,Østfold Hospital Trust,Kalnes,Noruega

  • Novartis Pharmaceuticals AG,Basel,Швейцария

  • Department of Medical and Surgical Sciences,University of Trieste,Trieste,Italy

  • Novartis Pharma Corp, Basel, Switzerland

  • Novartis Pharmaceuticals Corporation East Hanover NJ United States

  • Novartis Pharma AG,Basel,Svizzera

  • Centre for Haematology, Department of Immunology and Inflammation,Imperial College London, Hammersmith Hospital,London,Vereinigtes Königreich

  • Novartis Pharma AG,Basel,Zwitserland

  • Centre for Haematology, Department of Immunology and Inflammation,Imperial College London, Hammersmith Hospital,London,Vereinigtes Königreich

  • Department of Medicine,Østfold Hospital Trust,Kalnes,Noruega

  • Department of Medical and Surgical Sciences,University of Trieste,Trieste,Italy

  • Department of Medicine,Østfold

  • Novartis Pharmaceutical Corporation, East Hanover, NJ

  • Department of Medicine,Østfold Hospital Trust,Kalnes,Noruega

  • Department of Medicine,Østfold Hospital Trust,Kalnes,Noruega

  • Department of Medical and Surgical Sciences,University of Trieste,Trieste,Italy

  • Novartis Pharma AG,Basel,Svizzera

  • Novartis Pharmaceutical Corporation, East Hanover, NJ

  • Department of Medicine,Østfold Hospital Trust,Kalnes,Noruega

  • Department of Medical and Surgical Sciences,University of Trieste,Trieste,Italy

  • Novartis Pharma AG,Basel,Svizzera

  • Novartis Pharma AG,Basel,Svizzera

  • Novartis Pharma AG,Basel,Svizzera

  • Centre for Haematology, Department of Immunology and Inflammation,Imperial College London, Hammersmith Hospital,London,Vereinigtes Königreich

  • Novartis Pharmaceutical Corporation, East Hanover, NJ

  • Novartis Pharmaceuticals Corporation,East Hanover,Estados Unidos

Locations

  • Norway

  • Italy

  • Switzerland

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Eltrombopag

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • NCT03524612

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved